Recent Company News

• 07:48 PM ET Oct 09, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 01:03 PM ET Oct 09, 2026
  

  Cancer Vaccines Are the NIH's Next 'Big Bet' - NY Times

• 08:57 AM ET Oct 08, 2026
  

  BioNTech initiated hold at Argus Research ($95.25, 0.00)

• 04:54 PM ET Sep 28, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:26 AM ET Sep 28, 2026
  

  BioNTech to shutter sites in Germany, Singapore as no buyers emerge - Reuters ($98.52, 0.00)

• 01:32 PM ET Sep 17, 2026
  

  Health Canada authorizes Pfizer and BioNTech's Omicron XFG-adapted COVID-19 Vaccine ($27.64, +0.18)

• 09:22 AM ET Sep 14, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 08:52 AM ET Sep 14, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:21 AM ET Sep 14, 2026
  

  StreetAccount Summary - US Pre-market trading

• 04:07 AM ET Sep 14, 2026
  

  BioNTech, OncoC4 present first OS data from stage 1 of PRESERVE-003 trial of gotistobart at WCLC ($96.73, 0.00)